Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM159PT
TNBC
Basal B
QNZ
NFkB
NFKB
7531.096
uM
inf
999.01730
0.7706 0.1998 0.3426 0.0446
0.6665
3.5504
SUM159PT
TNBC
Basal B
Ribavirin
15402.211
uM
51.66870
999.82030
0.4628 -0.6950 0.2941 0.1569
0.8782
3.0887
SUM159PT
TNBC
Basal B
Ro 32-0432
PKC
PKC
10520.142
uM
inf
inf
1.0500 1.0500 0.0000 -0.0236
-0.3274
3.1766
SUM159PT
TNBC
Basal B
SB-3CT
MMP2/9
MMP
11057.144
uM
22.69590
50.71310
-0.4344 -1.0000 1.3664 0.1434
0.9948
3.7784
SUM159PT
TNBC
Basal B
Selumetinib
MEK
MAPK
11057.155
uM
54.25520
19.05870
0.4787 0.0885 0.1862 0.2584
0.9646
4.1614
SUM159PT
TNBC
Basal B
Sigma A6730
AKT
AKT
10520.141
uM
11.09120
20.90010
-0.7115 -0.9538 1.6846 0.2015
0.9952
3.6374
SUM159PT
TNBC
Basal B
Sigma A6730
AKT
AKT
11057.158
uM
11.04450
21.67290
-0.7343 -1.0000 1.6297 0.2053
0.9975
3.8594
SUM159PT
TNBC
Basal B
Sirolimus
MTOR
MTOR
7920.068
uM
4.68180
9.92620
-0.2346 -0.1745 0.3983 0.3470
0.6243
4.3418
SUM159PT
TNBC
Basal B
Sirolimus
MTOR
MTOR
9042.068
uM
0.13193
17.36430
-0.7962 -1.0000 0.2251 0.6042
0.6577
1.8008
SUM159PT
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7531.085
uM
36.49060
81.30910
-0.7688 -1.0000 1.3712 0.2215
0.9964
3.5188
SUM159PT
TNBC
Basal B
Sulindac sulfide
COX1/2
COX
10520.136
uM
inf
inf
0.9767 0.9767 0.0000 -0.0015
0.0597
4.0331
SUM159PT
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7531.067
uM
2.42180
5.2160
-0.7605 -0.8093 1.2547 0.5048
0.9969
3.6061
SUM159PT
TNBC
Basal B
TAPI-0
TACE/Collagenase
7531.096
uM
inf
inf
0.8694 0.8694 0.0000 0.0391
0.3982
3.5504
SUM159PT
TNBC
Basal B
Taxol
TUBB
TUBB
9844.002
uM
0.01006
0.01523
-0.6394 -0.3874 1.3823 0.8015
0.9661
2.4608
SUM159PT
TNBC
Basal B
Taxol
TUBB
TUBB
7918.002
uM
0.02071
0.02464
-0.2669 -0.2406 2.2605 0.7152
0.9912
2.8377
SUM159PT
TNBC
Basal B
Taxol
TUBB
TUBB
13054.002
uM
0.00389
0.00463
-0.1850 -0.1586 1.5931 0.8001
0.9981
3.0574
SUM159PT
TNBC
Basal B
Taxol
TUBB
TUBB
13004.002
uM
0.00449
0.00513
-0.1960 -0.1508 1.9936 0.7840
0.9981
3.1387
SUM159PT
TNBC
Basal B
TCS 2312
CHK1
CHK
10520.14
uM
0.48877
0.61898
-0.3612 -0.3328 2.1599 0.4285
0.9923
3.7031
SUM159PT
TNBC
Basal B
TCS 2312
CHK1
CHK
11057.152
uM
1.15310
1.13690
0.0039 0.0251 3.6451 0.2485
0.9981
3.8541
SUM159PT
TNBC
Basal B
TCS PIM-1 1
Pim kinase
PIM
10520.135
uM
97.22130
40.41170
0.4897 0.4856 4.0427 0.0293
0.9568
3.6895
SUM159PT
TNBC
Basal B
TCS PIM-1 1
Pim kinase
PIM
11057.135
uM
inf
30.93790
0.6673 0.6670 4.9977 0.0270
0.9663
3.9340
SUM159PT
TNBC
Basal B
Temsirolimus
MTOR
MTOR
11057.144
uM
3.51290
26.67560
-0.7417 -1.0000 0.5419 0.4064
0.8413
3.7784
SUM159PT
TNBC
Basal B
Topotecan
TOP1
TOP
7918.007
uM
0.04050
0.03894
-0.4639 0.0892 4.9965 0.5953
0.6077
2.9756
SUM159PT
TNBC
Basal B
Topotecan
TOP1
TOP
7919.043
uM
4.94050
67.03450
-0.1227 -1.0000 0.4213 0.2990
0.9850
3.1744
SUM159PT
TNBC
Basal B
Torkinib
15402.211
uM
0.01202
0.01610
-0.0537 -0.0724 0.4628 0.6556
0.9950
3.0887